Seeking Alpha

Enzon Pharmaceuticals, Inc. (ENZN)

  • Mar. 19, 2013, 6:39 AM
    Enzon Pharmaceuticals (ENZN): Q4 EPS of -$0.11. Revenue of $10.6M. (PR)
    | Mar. 19, 2013, 6:39 AM | Comment!
Company Description
Enzon Pharmaceuticals Inc is related to sales of drugs by various companies. It generates revenues from the sales of products namely, PegIntron, Sylatron, Macugen and CIMZIA.
Sector: Healthcare
Industry: Biotechnology
Country: United States